Numinus Wellness Successfully Extracts Psilocybin From Mushrooms

Numinus Wellness (TSXV: NUMI) this morning announced that it has completed the extraction of psilocybe mushrooms, the first public company to do so in Canada, which follows their successful harvest earlier this year. The extracted product is to be used for the purposes of research and development.

The extraction solution is expected to be used in clinical trials as well as under the Special Access Programme, once amendments have been submitted to Health Canada requesting the required approvals to do so. The company is currently working towards standardizing psilocybin and multiple therapeutically important components to increase the efficacy of the extract.

The company then took a shot at firms looking to produce synthetic versions of psilocybin, a key risk to the firms extraction model, by stating, “While direct comparisons cannot be made, there is a clear recognition in the cannabis space that synthetic cannabinoids are far less attractive than naturally occurring cannabinoids. Numinus is of the view that, ultimately, nature knows best.”

Further details on the results of the process, such as quantities extracted of the compound, were not provided.

Numinus Wellness last traded at $1.79 on the TSX Venture.


Information for this briefing was found via Sedar and Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Verses Hits Commercialization Stage With Genius AI Platform

Related News

Psychedelics: The Eight Capital Primer

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are...

Monday, June 14, 2021, 03:38:00 PM

Numinus Wellness Sells Off Shares In Alto Neuroscience Ahead Of IPO

Numinus Wellness (TSX: NUMI) is reporting this morning that it has sold its interest in...

Thursday, February 1, 2024, 09:28:12 AM

Numinus Wellness: Eight Capital Initiates With $1.10 Price Target

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after...

Monday, September 20, 2021, 02:41:00 PM

Numinus Sells Utah Clinics For US$3.53 Million

Numinus Wellness (TSX: NUMI) is disposing of its US-based clinics in a transaction that is...

Friday, November 15, 2024, 08:03:39 AM

Numinus Sees Integrated VC, MAPS Lead $6.0 Million Funding Round

Numinus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that...

Friday, February 2, 2024, 09:00:02 AM